Barbara C. Jobst
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Barbara C. Jobst has a total of 488 co-authors. Here are the top co-authors by number of shared publications:
- Michael R. Sperling
Farber Institute for Neuroscience, Department of Neurology, Thomas Jefferson University, Philadelphia, USA
13 shared publications - Gregory A. Worrell
Department of Neurology Mayo Clinic Rochester Minnesota USA
11 shared publications - Bradford Burke Worrall
Departments of Neurology and Public Health Sciences, University of Virginia, Charlottesville
8 shared publications - Bradley C. Lega
Department of Neurological Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA
8 shared publications - Linda Ann Hershey
From the American Academy of Neurology (P.K.B., K.M.P., S.L.Q., A.R.), Minneapolis, MN; Department of Radiology and Nuclear Medicine (F.B.), VU University Medical Centre, Amsterdam, the Netherlands; Queen Square Institute of Neurology and Centre for Medical Image Computing (F.B.), University College London, United Kingdom; Larner College of Medicine (R.B.), University of Vermont, Burlington, VT; Department of Neurology (B.C.C.), Veterans Affairs Ann Arbor Health System, MI; Department of...
8 shared publications - Michael J. Kahana
University of Pennsylvania
8 shared publications
Latest Publications
- Open Access
- 30 October 2026
- Published by MDPI AG in Preprints.org
Accelerated Long-Term Forgetting as a Candidate Behavioral Marker of Hippocampal Network Vulnerability: A Critical Review of Implications for Epilepsy, Cognitive Aging, and Preclinical Neurodegeneration
Memory impairment is a common cognitive comorbidity of epilepsy and can substantially affect quality of life. Most memory testing tasks measure learning and memory over about 20 to 30 minutes, which may not capture the complexity of long-term memory formation. Because long-term memories continue to consolidate over hours or days, weeks, or longer, more comprehensive evaluation methods may be needed to assess whether memories persist over time.This raises an important question: Do conventional memory assessments adequately assess the longevity of memory? One issue is accelerated long-term forgetting (ALF), characterized by relatively intact learning and short-delay recall, followed by disproportionately rapid forgetting over longer intervals. ALF has been studied most extensively in epilepsy and has been associated with abnormalities involving the hippocampus and related memory networks. In temporal lobe epilepsy, accelerated memory decay has been demonstrated between conventional delayed and longer-term recall. Impaired systems consolidation is a leading explanation, with possible contributions from sleep disruption, interictal epileptiform activity, and broader network dysfunction. However, substantial methodological variability across studies, including differences in learning procedures, retention intervals, outcome measures, and definitions of abnormal forgetting, limits comparison and interpretation of findings.This review integrates current knowledge from diverse areas, including epilepsy, neuroscience, sleep studies, brain imaging, and aging. It discusses the role of ALF as a measure of memory deficits, explores its biological basis, and assesses the strengths and limitations of existing research. We also consider whether ALF could serve as a candidate behavioral marker of hippocampal network vulnerability. Before this role can be established, extended-delay memory paradigms require greater methodological standardization and prospective multimodal validation. Understanding memory persistence as a key component of cognitive function may help refine memory assessment tools, improve understanding of neurological conditions, and develop new approaches to assessing cognitive health in patients with epilepsy and other neurological conditions.
- 30 October 2026
- Published by MDPI AG in Preprints.org
Open AccessAccelerated Long-Term Forgetting as a Candidate Behavioral Marker of Hippocampal Network Vulnerability: A Critical Review of Implications for Epilepsy, Cognitive Aging, and Preclinical Neurodegeneration
Memory impairment is a common cognitive comorbidity of epilepsy and can substantially affect quality of life. Most memory testing tasks measure learning and memory over about 20 to 30 minutes, which may not capture the complexity of long-term memory formation. Because long-term memories continue to consolidate over hours or days, weeks, or longer, more comprehensive evaluation methods may be needed to assess whether memories persist over time.This raises an important question: Do conventional memory assessments adequately assess the longevity of memory? One issue is accelerated long-term forgetting (ALF), characterized by relatively intact learning and short-delay recall, followed by disproportionately rapid forgetting over longer intervals. ALF has been studied most extensively in epilepsy and has been associated with abnormalities involving the hippocampus and related memory networks. In temporal lobe epilepsy, accelerated memory decay has been demonstrated between conventional delayed and longer-term recall. Impaired systems consolidation is a leading explanation, with possible contributions from sleep disruption, interictal epileptiform activity, and broader network dysfunction. However, substantial methodological variability across studies, including differences in learning procedures, retention intervals, outcome measures, and definitions of abnormal forgetting, limits comparison and interpretation of findings.This review integrates current knowledge from diverse areas, including epilepsy, neuroscience, sleep studies, brain imaging, and aging. It discusses the role of ALF as a measure of memory deficits, explores its biological basis, and assesses the strengths and limitations of existing research. We also consider whether ALF could serve as a candidate behavioral marker of hippocampal network vulnerability. Before this role can be established, extended-delay memory paradigms require greater methodological standardization and prospective multimodal validation. Understanding memory persistence as a key component of cognitive function may help refine memory assessment tools, improve understanding of neurological conditions, and develop new approaches to assessing cognitive health in patients with epilepsy and other neurological conditions.
- Open Access
- 26 October 2026
- Published by SAGE Publications in Epilepsy Currents
American Epilepsy Society/Congress of Neurological Surgeons Epilepsy Surgery Clinical Practice Guideline
This practice guideline from the American Epilepsy Society (AES) and the Congress of Neurological Surgeons (CNS) provides evidence-based recommendations for surgical treatment of epilepsy for adults and children. It is an update to previous practice parameters published by the Academy of Neurology in 2003. The multidisciplinary panel addressed resective procedures for mesial temporal epilepsy (MTLE), neocortical epilepsy, and resection/disconnection of hypothalamic hamartoma. It also examined evidence for callosotomy in developmental and epileptic encephalopathies. It did not intentionally address neurostimulation treatment. A comprehensive literature review was conducted using the Grading of Recommendations Assessment, Development and Education (GRADE) methodology, and GRADE was also used for decision-making. This guideline considers not only seizure outcomes but also other critical and important outcomes. Seizures, quality of life, mortality, adverse events, and verbal memory loss were considered critical outcomes, while other neuropsychological deficits besides verbal memory loss (ie, naming, fluency), neuropsychiatric, and social outcomes were considered important outcomes. Following the GRADE process, the following strong recommendation was made based on a moderate level of evidence: (1) anterior temporal lobectomy (ATL) is recommended for people with MTLE at low risk for cognitive decline. Due to very low to low certainty of evidence the panel suggested the following conditional recommendations: (1) ATL for people with MTLE at high risk for cognitive decline, (2) selective amygdalo-hippocampectomy (SAH) in MTLE, (3) laser interstitial thermal therapy (LITT) in MTLE, (4) neocortical resection in neocortical epilepsy, and (5) callosotomy in people with drop attacks, Lennox-Gastaut Syndrome (LGS) or developmental and epileptic encephalopathies. The panel recognized that conditional recommendations need to account for individual patient circumstances and mandate shared decision-making to ensure that decisions align with each person's values and preferences. For hypothalamic hamartoma, the panel strongly recommended LITT despite low levels of evidence due to a paradigmatic situation where open surgery has significant risks that outweigh the benefits. If LITT is not available, the panel suggested radiosurgery for hypothalamic hamartoma (conditional recommendation). The panel highlighted that every person with drug-resistant epilepsy should have access to a tertiary epilepsy care center that performs surgical procedures and advanced epilepsy diagnostics (good practice statement).
- 26 October 2026
- Published by SAGE Publications in Epilepsy Currents
Open AccessAmerican Epilepsy Society/Congress of Neurological Surgeons Epilepsy Surgery Clinical Practice Guideline
This practice guideline from the American Epilepsy Society (AES) and the Congress of Neurological Surgeons (CNS) provides evidence-based recommendations for surgical treatment of epilepsy for adults and children. It is an update to previous practice parameters published by the Academy of Neurology in 2003. The multidisciplinary panel addressed resective procedures for mesial temporal epilepsy (MTLE), neocortical epilepsy, and resection/disconnection of hypothalamic hamartoma. It also examined evidence for callosotomy in developmental and epileptic encephalopathies. It did not intentionally address neurostimulation treatment. A comprehensive literature review was conducted using the Grading of Recommendations Assessment, Development and Education (GRADE) methodology, and GRADE was also used for decision-making. This guideline considers not only seizure outcomes but also other critical and important outcomes. Seizures, quality of life, mortality, adverse events, and verbal memory loss were considered critical outcomes, while other neuropsychological deficits besides verbal memory loss (ie, naming, fluency), neuropsychiatric, and social outcomes were considered important outcomes. Following the GRADE process, the following strong recommendation was made based on a moderate level of evidence: (1) anterior temporal lobectomy (ATL) is recommended for people with MTLE at low risk for cognitive decline. Due to very low to low certainty of evidence the panel suggested the following conditional recommendations: (1) ATL for people with MTLE at high risk for cognitive decline, (2) selective amygdalo-hippocampectomy (SAH) in MTLE, (3) laser interstitial thermal therapy (LITT) in MTLE, (4) neocortical resection in neocortical epilepsy, and (5) callosotomy in people with drop attacks, Lennox-Gastaut Syndrome (LGS) or developmental and epileptic encephalopathies. The panel recognized that conditional recommendations need to account for individual patient circumstances and mandate shared decision-making to ensure that decisions align with each person's values and preferences. For hypothalamic hamartoma, the panel strongly recommended LITT despite low levels of evidence due to a paradigmatic situation where open surgery has significant risks that outweigh the benefits. If LITT is not available, the panel suggested radiosurgery for hypothalamic hamartoma (conditional recommendation). The panel highlighted that every person with drug-resistant epilepsy should have access to a tertiary epilepsy care center that performs surgical procedures and advanced epilepsy diagnostics (good practice statement).
- Open Access
- 26 October 2026
- Published by Wolters Kluwer Health in Neurosurgery
American Epilepsy Society/Congress of Neurological Surgeons Epilepsy Surgery Clinical Practice Guideline
This practice guideline from the American Epilepsy Society and the Congress of Neurological Surgeons provides evidence-based recommendations for surgical treatment of epilepsy for adults and children. It is an update to previous practice parameters published by the Academy of Neurology in 2003. The multidisciplinary panel addressed resective procedures for mesial temporal epilepsy, neocortical epilepsy, and resection/disconnection of hypothalamic hamartoma. It also examined evidence for callosotomy in developmental and epileptic encephalopathies. It did not intentionally address neurostimulation treatment. A comprehensive literature review was conducted using Grading of Recommendations Assessment, Development, and Education methodology, and it was also used for decision making. This guideline considers not only seizure outcomes but also other critical and important outcomes. Seizures, quality of life, mortality, adverse events, and verbal memory loss were considered critical outcomes, whereas other neuropsychological deficits besides verbal memory loss (ie, naming, fluency), neuropsychiatric, and social outcomes were considered important outcomes.
- 26 October 2026
- Published by Wolters Kluwer Health in Neurosurgery
Open AccessAmerican Epilepsy Society/Congress of Neurological Surgeons Epilepsy Surgery Clinical Practice Guideline
This practice guideline from the American Epilepsy Society and the Congress of Neurological Surgeons provides evidence-based recommendations for surgical treatment of epilepsy for adults and children. It is an update to previous practice parameters published by the Academy of Neurology in 2003. The multidisciplinary panel addressed resective procedures for mesial temporal epilepsy, neocortical epilepsy, and resection/disconnection of hypothalamic hamartoma. It also examined evidence for callosotomy in developmental and epileptic encephalopathies. It did not intentionally address neurostimulation treatment. A comprehensive literature review was conducted using Grading of Recommendations Assessment, Development, and Education methodology, and it was also used for decision making. This guideline considers not only seizure outcomes but also other critical and important outcomes. Seizures, quality of life, mortality, adverse events, and verbal memory loss were considered critical outcomes, whereas other neuropsychological deficits besides verbal memory loss (ie, naming, fluency), neuropsychiatric, and social outcomes were considered important outcomes.
- Open Access
- 13 July 2026
- Published by SAGE Publications in Epilepsy Currents
Surgical Management in Patients With Drug-Resistant Epilepsy: A Summary of Four Systematic Reviews and Meta-Analyses
Drug-resistant epilepsy (DRE) may lead to substantial morbidity, impaired quality of life (QoL), and increased mortality. Clinicians increasingly use surgical interventions to manage DRE, but uncertainty remains regarding their comparative benefits and harms across epilepsy syndromes. We conducted 4 systematic reviews and meta-analyses to inform the American Epilepsy Society (AES) and Congress of Neurological Surgeons (CNS) guidelines on surgical management of DRE. We searched MEDLINE, Embase, and CENTRAL from inception to August 2024 for randomized controlled trials (RCTs) and nonrandomized studies (NRS). We evaluated (1) resective or ablative surgery versus medical therapy in drug-resistant mesiotemporal lobe epilepsy (DR-MTLE); (2) resective or ablative surgery versus medical therapy in drug-resistant neocortical epilepsy (DR-NE); (3) callosotomy versus vagus nerve stimulation (VNS) in developmental and epileptic encephalopathies (DEEs) with drop attacks; and (4) ablative versus resective surgery in hypothalamic hamartoma (HH). The panel prioritized the following critical outcomes: seizure freedom, QoL, neuropsychological, neuropsychiatric, and social outcomes, and serious adverse events. We assessed certainty of evidence using the Grading of Recommendations Assessment, Development and Evaluation approach. We included 59 studies comprising 4868 participants. In DR-MTLE, moderate-certainty evidence from RCTs showed that anterior temporal lobectomy (ATL), compared with medical therapy, probably increases seizure freedom and improves QoL. The evidence was very uncertain regarding the effects of selective amygdalohippocampectomy, laser interstitial thermal therapy (LITT), and radiosurgery in patients with DRE. In DR-NE, very low-certainty evidence suggested that seizure freedom may occur after resective surgery. However, we did not identify any eligible studies evaluating ablative surgery in this population. In DEE, very low-certainty evidence suggested that, when compared to VNS, callosotomy may improve seizure outcomes but may also increase serious adverse events. In HH, evidence for LITT and radiosurgery was found to be very uncertain. Across reviews, the most common reason for downgrading the certainty of evidence was risk of bias and imprecision. Moderate-certainty evidence supports ATL in selected patients with DR-MTLE. For other surgical approaches and epilepsy syndromes, the evidence remains very uncertain, highlighting the need for better comparative studies.
- 13 July 2026
- Published by SAGE Publications in Epilepsy Currents
Open AccessSurgical Management in Patients With Drug-Resistant Epilepsy: A Summary of Four Systematic Reviews and Meta-Analyses
Drug-resistant epilepsy (DRE) may lead to substantial morbidity, impaired quality of life (QoL), and increased mortality. Clinicians increasingly use surgical interventions to manage DRE, but uncertainty remains regarding their comparative benefits and harms across epilepsy syndromes. We conducted 4 systematic reviews and meta-analyses to inform the American Epilepsy Society (AES) and Congress of Neurological Surgeons (CNS) guidelines on surgical management of DRE. We searched MEDLINE, Embase, and CENTRAL from inception to August 2024 for randomized controlled trials (RCTs) and nonrandomized studies (NRS). We evaluated (1) resective or ablative surgery versus medical therapy in drug-resistant mesiotemporal lobe epilepsy (DR-MTLE); (2) resective or ablative surgery versus medical therapy in drug-resistant neocortical epilepsy (DR-NE); (3) callosotomy versus vagus nerve stimulation (VNS) in developmental and epileptic encephalopathies (DEEs) with drop attacks; and (4) ablative versus resective surgery in hypothalamic hamartoma (HH). The panel prioritized the following critical outcomes: seizure freedom, QoL, neuropsychological, neuropsychiatric, and social outcomes, and serious adverse events. We assessed certainty of evidence using the Grading of Recommendations Assessment, Development and Evaluation approach. We included 59 studies comprising 4868 participants. In DR-MTLE, moderate-certainty evidence from RCTs showed that anterior temporal lobectomy (ATL), compared with medical therapy, probably increases seizure freedom and improves QoL. The evidence was very uncertain regarding the effects of selective amygdalohippocampectomy, laser interstitial thermal therapy (LITT), and radiosurgery in patients with DRE. In DR-NE, very low-certainty evidence suggested that seizure freedom may occur after resective surgery. However, we did not identify any eligible studies evaluating ablative surgery in this population. In DEE, very low-certainty evidence suggested that, when compared to VNS, callosotomy may improve seizure outcomes but may also increase serious adverse events. In HH, evidence for LITT and radiosurgery was found to be very uncertain. Across reviews, the most common reason for downgrading the certainty of evidence was risk of bias and imprecision. Moderate-certainty evidence supports ATL in selected patients with DR-MTLE. For other surgical approaches and epilepsy syndromes, the evidence remains very uncertain, highlighting the need for better comparative studies.
- Open Access
- 12 May 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 106 (9) , e214875
Postapproval Study for Brain-Responsive Neurostimulation for Drug-Resistant Focal Epilepsy
Background and ObjectivesNeuromodulation therapies are approved for the treatment of focal epilepsy based on data from randomized controlled trials (RCTs). After approval of a responsive direct bra...
- 12 May 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 106 (9) , e214875
Open AccessPostapproval Study for Brain-Responsive Neurostimulation for Drug-Resistant Focal Epilepsy
Background and ObjectivesNeuromodulation therapies are approved for the treatment of focal epilepsy based on data from randomized controlled trials (RCTs). After approval of a responsive direct bra...
- Open Access
- 10 October 2025
- Published by Springer Nature in Clinical Epileptology
- Vol. 38 (4) , 278-295
Revidierte Klassifikation epileptischer Anfälle: Positionspapier der Internationalen Liga gegen Epilepsie
Zusammenfassung: Die Internationale Liga gegen Epilepsie (ILAE) hat die operationale Klassifikation epileptischer Anfälle 2017 auf der Grundlage der damals entwickelten Rahmenbedingungen aktualisiert. In diese Überarbeitung wurden die publizierten Erfahrungen mit der Umsetzung der 2017er-Klassifikation einbezogen. Eine 37 Personen zählende Arbeitsgruppe wurde vom ILAE-Exekutivausschuss eingesetzt. Die internationalen Expertinnen und Experten aus allen ILAE-Regionen wandten ein modifiziertes Delphi-Verfahren an, bei dem für jeden Vorschlag ein Konsens von mehr als zwei Dritteln erforderlich war. Nach Veröffentlichung auf der ILAE-Homepage mit dem Ersuchen, Kommentare zu dem Entwurf einzugeben, ernannte der Exekutivausschuss 7 zusätzliche Sachverständige für die Arbeitsgruppe zur Überarbeitung des Positionspapieres, um die eingegangenen Kommentare zu diskutieren und gegebenenfalls einzubeziehen. Die aktualisierte Klassifikation behält die Hauptklassen von Anfällen bei: fokal, generalisiert, unbekannt (ob fokal oder generalisiert) und nicht klassifiziert. Taxonomische Regeln unterscheiden zwischen Klassifikatoren , die biologische Klassen widerspiegeln und sich direkt auf die klinische Behandlung auswirken, und Deskriptoren , die andere wichtige Anfallsmerkmale angeben. Fokale Anfälle und Anfälle unbekannten Ursprungs werden darüber hinaus nach dem Bewusstseinszustand des Patienten während des Anfalls klassifiziert, je nachdem ob eine Bewusstseinsstörung vorliegt oder nicht. Die Bewertung, ob eine Bewusstseinsstörung vorliegt, wird durch Gewahrsein (engl. „awareness“) und Reaktionsfähigkeit (engl. „responsiveness“) während eines Anfalls und erhaltene Erinnerung (engl. „recall“) nach einem Anfall klinisch operationalisiert. Wenn der Bewusstseinszustand nicht bestimmbar ist, wird der Anfall unter dem übergeordneten Begriff, d. h. der Hauptanfallsklasse (fokaler Anfall oder Anfall unbekannten Ursprungs) klassifiziert. Generalisierte Anfälle werden in Absencen, generalisierte tonisch-klonische Anfälle und andere generalisierte Anfälle eingeteilt, wobei jetzt auch der negative Myoklonus als Anfallstyp beschrieben wird. Anfälle werden in der Grundversion als solche mit oder ohne beobachtbare Manifestationen beschrieben, während eine erweiterte Version die chronologische Abfolge der Anfallssemiologie verwendet. Diese aktualisierte Klassifikation umfasst 4 Hauptklassen und nur noch 21 Anfallstypen (und nicht mehr 63 wie in der 2017 Klassifikation; Anm. d. Übersetzer). Besonderer Wert wurde auf die Übersetzbarkeit in andere Sprachen jenseits von Englisch gelegt. Ziel ist es, eine gemeinsame Sprache für alle im Bereich Epilepsie tätigen Gesundheitsfachkräfte zu schaffen – von ressourcenarmen Gebieten bis hin zu hoch spezialisierten Zentren – und leicht zugängliche Begriffe für Patientinnen und Patienten sowie Betreuungspersonen bereitzustellen.
- 10 October 2025
- Published by Springer Nature in Clinical Epileptology
- Vol. 38 (4) , 278-295
Open AccessRevidierte Klassifikation epileptischer Anfälle: Positionspapier der Internationalen Liga gegen Epilepsie
Zusammenfassung: Die Internationale Liga gegen Epilepsie (ILAE) hat die operationale Klassifikation epileptischer Anfälle 2017 auf der Grundlage der damals entwickelten Rahmenbedingungen aktualisiert. In diese Überarbeitung wurden die publizierten Erfahrungen mit der Umsetzung der 2017er-Klassifikation einbezogen. Eine 37 Personen zählende Arbeitsgruppe wurde vom ILAE-Exekutivausschuss eingesetzt. Die internationalen Expertinnen und Experten aus allen ILAE-Regionen wandten ein modifiziertes Delphi-Verfahren an, bei dem für jeden Vorschlag ein Konsens von mehr als zwei Dritteln erforderlich war. Nach Veröffentlichung auf der ILAE-Homepage mit dem Ersuchen, Kommentare zu dem Entwurf einzugeben, ernannte der Exekutivausschuss 7 zusätzliche Sachverständige für die Arbeitsgruppe zur Überarbeitung des Positionspapieres, um die eingegangenen Kommentare zu diskutieren und gegebenenfalls einzubeziehen. Die aktualisierte Klassifikation behält die Hauptklassen von Anfällen bei: fokal, generalisiert, unbekannt (ob fokal oder generalisiert) und nicht klassifiziert. Taxonomische Regeln unterscheiden zwischen Klassifikatoren , die biologische Klassen widerspiegeln und sich direkt auf die klinische Behandlung auswirken, und Deskriptoren , die andere wichtige Anfallsmerkmale angeben. Fokale Anfälle und Anfälle unbekannten Ursprungs werden darüber hinaus nach dem Bewusstseinszustand des Patienten während des Anfalls klassifiziert, je nachdem ob eine Bewusstseinsstörung vorliegt oder nicht. Die Bewertung, ob eine Bewusstseinsstörung vorliegt, wird durch Gewahrsein (engl. „awareness“) und Reaktionsfähigkeit (engl. „responsiveness“) während eines Anfalls und erhaltene Erinnerung (engl. „recall“) nach einem Anfall klinisch operationalisiert. Wenn der Bewusstseinszustand nicht bestimmbar ist, wird der Anfall unter dem übergeordneten Begriff, d. h. der Hauptanfallsklasse (fokaler Anfall oder Anfall unbekannten Ursprungs) klassifiziert. Generalisierte Anfälle werden in Absencen, generalisierte tonisch-klonische Anfälle und andere generalisierte Anfälle eingeteilt, wobei jetzt auch der negative Myoklonus als Anfallstyp beschrieben wird. Anfälle werden in der Grundversion als solche mit oder ohne beobachtbare Manifestationen beschrieben, während eine erweiterte Version die chronologische Abfolge der Anfallssemiologie verwendet. Diese aktualisierte Klassifikation umfasst 4 Hauptklassen und nur noch 21 Anfallstypen (und nicht mehr 63 wie in der 2017 Klassifikation; Anm. d. Übersetzer). Besonderer Wert wurde auf die Übersetzbarkeit in andere Sprachen jenseits von Englisch gelegt. Ziel ist es, eine gemeinsame Sprache für alle im Bereich Epilepsie tätigen Gesundheitsfachkräfte zu schaffen – von ressourcenarmen Gebieten bis hin zu hoch spezialisierten Zentren – und leicht zugängliche Begriffe für Patientinnen und Patienten sowie Betreuungspersonen bereitzustellen.
- 1 August 2025
- Published by Wolters Kluwer Health in Neurology Clinical Practice
- Vol. 15 (4) , e200515
Let Our Patients Sleep
- 1 August 2025
- Published by Wolters Kluwer Health in Neurology Clinical Practice
- Vol. 15 (4) , e200515
Let Our Patients Sleep
- 8 July 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 105 (1)
Message From the Editors to Our Reviewers
- 8 July 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 105 (1)
Message From the Editors to Our Reviewers
- Open Access
Low and high frequency signatures of impaired consciousness in temporal lobe seizures
Impaired consciousness is a debilitating and unpredictable outcome of mesial temporal lobe seizures whose mechanisms to date remain unclear. Moreover, questions about the relationship between impaired consciousness and lateralization, hemispheric spread and electrophysiological characteristics of seizures are yet to be answered. To address these gaps, we conducted in-depth investigation of behavioral and intracranial EEG data from 186 mesial temporal lobe seizures of 51 patients with intractable mesial temporal lobe epilepsy. We found that bilateral mesial temporal spread of seizures is not a necessary condition for impaired consciousness, although seizures with bilateral mesial temporal involvement were significantly more likely to have impaired consciousness than unilateral seizures. Contrary to prior belief, we found no relationship between the onset side (left vs. right temporal lobe or language dominant vs. non-dominant lobe) of seizures and the probability of impaired consciousness. Lastly, we established that widespread increases in slow-wave activity (delta band) in extratemporal cortical areas, as well as increases in fast activity (beta band) in the temporal lobes were both robust markers of seizures with impaired consciousness and could predict ictal impairment with up to 86% accuracy. Our findings shed new light on networks that underlie impaired consciousness in temporal lobe epilepsy and may help guide deep brain stimulation of such systems (e.g. via thalamic nuclei) as a potential intervention to improve consciousness during seizures.
Open AccessLow and high frequency signatures of impaired consciousness in temporal lobe seizures
Impaired consciousness is a debilitating and unpredictable outcome of mesial temporal lobe seizures whose mechanisms to date remain unclear. Moreover, questions about the relationship between impaired consciousness and lateralization, hemispheric spread and electrophysiological characteristics of seizures are yet to be answered. To address these gaps, we conducted in-depth investigation of behavioral and intracranial EEG data from 186 mesial temporal lobe seizures of 51 patients with intractable mesial temporal lobe epilepsy. We found that bilateral mesial temporal spread of seizures is not a necessary condition for impaired consciousness, although seizures with bilateral mesial temporal involvement were significantly more likely to have impaired consciousness than unilateral seizures. Contrary to prior belief, we found no relationship between the onset side (left vs. right temporal lobe or language dominant vs. non-dominant lobe) of seizures and the probability of impaired consciousness. Lastly, we established that widespread increases in slow-wave activity (delta band) in extratemporal cortical areas, as well as increases in fast activity (beta band) in the temporal lobes were both robust markers of seizures with impaired consciousness and could predict ictal impairment with up to 86% accuracy. Our findings shed new light on networks that underlie impaired consciousness in temporal lobe epilepsy and may help guide deep brain stimulation of such systems (e.g. via thalamic nuclei) as a potential intervention to improve consciousness during seizures.